Omega-3 Care

Omega-3 Care is a healthcare company specializing in the development of high-purity, pharmaceutical-grade omega-3 fatty acid products. The company utilizes its proprietary Advanced Lipid Technologies (ALT) platform to enhance the bioavailability and absorption of lipophilic compounds. Its primary commercial focus is on concentrated EPA and DHA formulations designed for the management of cardiovascular health and hypertriglyceridemia. Historically, the company operated in close association with Sancilio & Company, contributing to the development of lipid-based therapeutic candidates. One of its notable research efforts included the development of Altemia, a specialized formulation for the treatment of sickle cell disease. Following the financial restructuring of its parent organization in 2018, the company's assets and intellectual property were largely transitioned to new ownership.